Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorWestern Galilee Hospital-Nahariya
About this trial
The purpose of this study is to compare maternal outcomes such as increased hemoglobin need for blood transfusion and hemoglobin level before and post partum in women with hemoglobin \<9 gr/dl , treated with venofer and women treated with ferinject.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Allergy to one of the study's drugs
IV iron treatment in the last month
Underlying medical conditions associated with anemia, such as thalassemia Major, renal insufficiency, or spherocytosis
Twin pregnancy
Trial design
Design model
Parallel
Treatments tested in this trial
Venofer 200 MG Per 10 ML Injection
Drugtreat anemia with venofer up to 5 doses
Ferinject
Drugferinject 500 mg, once a week for 2 weeks
Treatment groups
200 Participants
are divided into 2 treatment groupsGroup A: venoferActive comparator 1 intervention
Group B: FerinjectActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
ratio of women with Hb level >11 at delivery
Hb level
Time frame
at delivery2
postpartum Hb level
gr/dl
Time frame
during 48 hours after deliverySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov